Beam Therapeutics Inc (BEAM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Sales | 377,709 | 60,920 | 51,844 | 24 | 18 |
| Gross Profit | 377,709 | 60,920 | 51,844 | 24 | 18 |
| Operating Expenses | 554,194 | 399,399 | 444,309 | 132,784 | 75,172 |
| Operating Income | -176,485 | -338,479 | -392,465 | -132,760 | -75,154 |
| Other Income | 45,324 | 52,801 | 21,827 | -61,832 | -3,172 |
| Pre-tax Income | -131,161 | -285,678 | -370,638 | -194,592 | -78,326 |
| Income Tax | 1,366 | 3,410 | N/A | N/A | N/A |
| Net Income Continuous | -132,527 | -289,088 | -370,638 | -194,592 | -78,326 |
| Net Income | $-132,527 | $-289,088 | $-370,638 | $-194,592 | $-78,326 |
| EPS Basic Total Ops | -1.72 | -4.13 | -5.77 | -4.19 | -14.05 |
| EPS Basic Continuous Ops | -1.72 | -4.13 | -5.77 | -4.16 | -12.09 |
| EPS Diluted Total Ops | -1.72 | -4.13 | -5.77 | -4.19 | -14.05 |
| EPS Diluted Continuous Ops | -1.72 | -4.13 | -5.77 | -4.16 | -12.09 |
| EPS Diluted Before Non-Recurring Items | -1.72 | -4.13 | -6.05 | -2.83 | -14.05 |
| EBITDA(a) | $-186,216 | $-333,742 | $-385,089 | $-127,907 | $-72,571 |